These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 510116)

  • 21. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.
    Waldhäusl WK; Bratusch-Marrain PR; Vierhapper H; Nowotny P
    Metabolism; 1983 May; 32(5):478-86. PubMed ID: 6341763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery.
    Schade DS; Eaton RP; Spencer W
    Diabetes Care; 1980; 3(1):9-14. PubMed ID: 6996975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programming of insulin delivery with meals during subcutaneous insulin infusion.
    Chisholm DJ; Kraegen EW; Zelenka GS
    Diabetes Care; 1981; 4(2):265-8. PubMed ID: 7011744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
    Toft-Nielsen MB; Madsbad S; Holst JJ
    Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus.
    Van Haeften TW; Bolli GB; Dimitriadis GD; Gottesman IS; Horwitz DL; Gerich JE
    Metabolism; 1986 Jul; 35(7):649-56. PubMed ID: 3523119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of plateau insulin levels achieved by intravenous or subcutaneous insulin infusion: evidence for low rates of subcutaneous degradation.
    Kraegen EW; Chisholm DJ; Hewett MJ
    Diabetes Care; 1983; 6(2):118-21. PubMed ID: 6343015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):49-51. PubMed ID: 395089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man.
    Schade DS; Eaton RP; Friedman NM; Spencer WJ
    Diabetologia; 1980 Jul; 19(1):35-9. PubMed ID: 6993266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overnight metabolic control with pulsed intermittent versus continuous subcutaneous insulin infusion.
    Levy-Marchal C; Albisser AM; Zinman B
    Diabetes Care; 1983; 6(4):356-60. PubMed ID: 6352209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
    Ryan AS; Egan JM; Habener JF; Elahi D
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of temporal distribution of calories on diurnal patterns of glucose levels and insulin secretion in NIDDM.
    Beebe CA; Van Cauter E; Shapiro ET; Tillil H; Lyons R; Rubenstein AH; Polonsky KS
    Diabetes Care; 1990 Jul; 13(7):748-55. PubMed ID: 2201497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
    Rini CJ; McVey E; Sutter D; Keith S; Kurth HJ; Nosek L; Kapitza C; Rebrin K; Hirsch L; Pettis RJ
    Drug Deliv Transl Res; 2015 Aug; 5(4):332-45. PubMed ID: 26037035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.